Millennium Management’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.18M | Buy |
+206,288
| New | +$7.49M | ﹤0.01% | 2373 |
|
|
2025
Q4 | – | Sell |
-12,935
| Closed | -$301K | – | 6513 |
|
|
2025
Q3 | $301K | Sell |
12,935
-2,107
| -14% | -$37K | ﹤0.01% | 5338 |
|
|
2025
Q2 | $222K | Buy |
+15,042
| New | +$276K | ﹤0.01% | 5317 |
|
|
2024
Q3 | – | Sell |
-12,256
| Closed | -$216K | – | 6518 |
|
|
2024
Q2 | $216K | Buy |
+12,256
| New | +$292K | ﹤0.01% | 5098 |
|
|
2023
Q4 | – | Sell |
-265
| Closed | -$5.06K | – | 6598 |
|
|
2023
Q3 | $5.06K | Buy |
+265
| New | +$6.48K | ﹤0.01% | 5880 |
|
|
2023
Q2 | – | Sell |
-1,095
| Closed | -$35K | – | 6736 |
|
|
2023
Q1 | $35K | Sell |
1,095
-507
| -32% | -$17.2K | ﹤0.01% | 5731 |
|
|
2022
Q4 | $42K | Sell |
1,602
-331
| -17% | -$10.9K | ﹤0.01% | 5843 |
|
|
2022
Q3 | $75K | Sell |
1,933
-1,534
| -44% | -$60.4K | ﹤0.01% | 6060 |
|
|
2022
Q2 | $104K | Buy |
3,467
+371
| +12% | +$9.51K | ﹤0.01% | 5909 |
|
|
2022
Q1 | $89K | Sell |
3,096
-563
| -15% | -$16.9K | ﹤0.01% | 6197 |
|
|
2021
Q4 | $146K | Sell |
3,659
-11
| -0.3% | -$591 | ﹤0.01% | 6085 |
|
|
2021
Q3 | $225K | Sell |
3,670
-3,696
| -50% | -$279K | ﹤0.01% | 6036 |
|
|
2021
Q2 | $672K | Buy |
7,366
+7,051
| +2,238% | +$714K | ﹤0.01% | 5030 |
|
|
2021
Q1 | $36K | Buy |
+315
| New | +$30.9K | ﹤0.01% | 5797 |
|
|
2020
Q4 | – | Sell |
-566
| Closed | -$40 | – | 5624 |
|
|
2020
Q3 | $40 | Buy |
+566
| New | +$49.7K | ﹤0.01% | 4313 |
|
|
2020
Q2 | – | Sell |
-1,221
| Closed | -$93K | – | 4637 |
|
|
2020
Q1 | $93K | Buy |
+1,221
| New | +$117K | ﹤0.01% | 3561 |
|
|
2019
Q4 | – | Sell |
-263
| Closed | -$16K | – | 4677 |
|
|
2019
Q3 | $16K | Sell |
263
-1
| -0.4% | -$56 | ﹤0.01% | 4096 |
|
|
2019
Q2 | $15K | Sell |
264
-11
| -4% | -$660 | ﹤0.01% | 3981 |
|
|
2019
Q1 | $19K | Buy |
275
+17
| +7% | +$1.65K | ﹤0.01% | 3919 |
|
|
2018
Q4 | $27K | Sell |
258
-113
| -30% | -$10.5K | ﹤0.01% | 3655 |
|
|
2018
Q3 | $11K | Sell |
371
-282
| -43% | -$13.2K | ﹤0.01% | 3839 |
|
|
2018
Q2 | $40K | Sell |
653
-1,723
| -73% | -$127K | ﹤0.01% | 3716 |
|
|
2018
Q1 | $387K | Buy |
2,376
+809
| +52% | +$198K | ﹤0.01% | 3125 |
|
|
2017
Q4 | $377K | Buy |
+1,567
| New | +$351K | ﹤0.01% | 3227 |
|
|
2017
Q3 | – | Sell |
-307
| Closed | -$61K | – | 3897 |
|
|
2017
Q2 | $61K | Buy |
+307
| New | +$64K | ﹤0.01% | 3352 |
|
|
2016
Q2 | – | Sell |
-7,165
| Closed | -$1.48M | – | 3619 |
|
|
2016
Q1 | $1.48M | Buy |
7,165
+4,728
| +194% | +$1.18M | ﹤0.01% | 1962 |
|
|
2015
Q4 | $664K | Buy |
2,437
+971
| +66% | +$272K | ﹤0.01% | 2502 |
|
|
2015
Q3 | $382K | Buy |
+1,466
| New | +$511K | ﹤0.01% | 2796 |
|
Other funds holding VTVT
SB
SL
BBA
TECP
VCM
VFT
6CM
Millennium Management's VTVT Position: Q1 2026 in Review
Millennium Management opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 206,288 shares worth $8.18M. The stake represents ﹤0.01% of the portfolio and ranks #2373 among its holdings. This is a return to the name: Millennium Management previously reported a position in VTVT as recently as Q3 2025.
Millennium Management first reported a position in VTVT in Q3 2015 and has held it in 28 quarters since. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.
- Millennium Management held 206,288 shares of vTv Therapeutics worth $8.18M as of Q1 2026.
- vTv Therapeutics was a new Millennium Management position in Q1 2026.
- vTv Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2373 holding.
- Millennium Management first reported a position in vTv Therapeutics in Q3 2015 and has held it in 28 quarters since.
- 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.